Standard Life PLC (LON:SDLF) narrowed its full-year 2025 statutory loss after tax to £394 million from £1.08 billion a year ...

Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri ...

According to MarketsandMarkets™, The Tank Mix Adjuvants Market is projected to reach USD 2.09 billion in 2026 and USD 2.71 ...

JPMorgan allows institutional clients to use Bitcoin and Ethereum as loan collateral within parts of its trading business.

Obexelimab marketing applications for the treatment of IgG4-RD expected to be submitted to the FDA in Q2 2026 and the EMA in H2 2026 based on ...